|
|
|
| Endoscopic hemostasis using self-expandable metal stent combined with PuraStatR for patient with high risk of post-endoscopic sphincterotomy bleeding (with video) |
| Takeshi Ogura ∗, Yuki Uba , Masahiro Yamamura , Nobu Nishioka , Hiroki Nishikawa |
2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan
∗ Corresponding author.
E-mail address: oguratakeshi0411@yahoo.co.jp (T. Ogura). |
|
|
|
|
Abstract Endoscopic sphincterotomy (EST) is an established technique for removal of bile duct stones and self-expandable metal stent (SEMS) deployment. However, bleeding can be considered an adverse event after EST, particularly for patients with high risk of bleeding such as those on hemodialysis. Among the various techniques reported for obtaining endoscopic hemostasis [1–3] , SEMS deployment is useful in terms of its tamponade effect, but bleeding can occur continuously even following SEMS deployment from the upper edge of the ampulla of Vater. In this situation, coagulation or endoscopic injection of epinephrine can be considered, but this might be complicated by the presence of ulcer formation. A novel hemostatic agent (PuraStatR , 3D Matrix Europe SAS, Caluireet- Cuire, France) has recently become available [4] . Here we describe a case of successful endoscopic hemostasis using SEMS combined with PuraStatR in a patient with high risk of post-EST bleeding.
|
|
|
|
|
|
|
|
|
2024, Vol. 23 
